Zoledronic Acid Initiated During the First Year of Androgen Deprivation Therapy Increases Bone Mineral Density in Patients With Prostate Cancer

Christopher W. Ryan, Dezheng Huo, Laurence M. Demers, Tomasz M. Beer, Leo V. Lacerna

Research output: Contribution to journal › Article › peer-review

113 Scopus citations

Fingerprint

Dive into the research topics of 'Zoledronic Acid Initiated During the First Year of Androgen Deprivation Therapy Increases Bone Mineral Density in Patients With Prostate Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences